Neuberg Anand Reference Laboratory appoints Dr Khalida Parveen Adnan as Chief of lab, Karnataka

Published On 2022-06-23 11:30 GMT | Update On 2022-06-23 12:06 GMT

Bangalore: Neuberg Anand Reference Laboratory has appointed Dr Khalida Parveen Adnanas as Chief of lab, Karnataka.

Dr Khalida has extensive experience of over 12 years in the clinical diagnostics industry, and her areas of expertise encompasses the entire spectrum of laboratory and quality management system which makes her one of the recognized laboratory professionals in India. She is the former Managing Director of MB Diagnostics and Healthcare Services, Bangalore.

She will play a key role of technical advisor, responsible forserving customers by constantly exceeding their expectations in terms of quality, service, value and time, in alignment with the moto and strategy of Neuberg Anand Reference Laboratory.

Read also: OPPI appoints Vivek Sehgal as new Director General

"We are pleased to have Dr Khalida as the Chief of Lab-Karnataka. She has a deep understanding of the diagnostic sector. With her robust and diverse experience, we are confident that the laboratory and 128 touch points will deliver better outcomes for more patients across Karnataka under her guidance. We also believe she will find new ways to structure the healthcare ecosystem together with our customers and embrace next-generation ideas and technologies that can transform the lives of patients" said Dr. Sujay Prasad, Medical Director, Neuberg Anand Reference Laboratory.

Read also: Herve Berdou appointed as Piramal Pharma Solutions new Chief Operating Officer

Dr Khalida Parveen Adnan, Chief of lab, Neuberg Anand Reference Laboratory said, "I look forward to being associated with Neuberg Anand at a time when diagnostics industry in India is witnessing exponential growth. With an aim to provide patients with a comprehensive range approach both with routine and specialized test menus with testing labs all over Karnataka.Neurberg Anand will bring its expert knowledge and state-of-the-art technology to serve the people of Karnataka in a better way towards quality healthcare."

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Comments Policy

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Neuberg Anand Reference Laboratory appoints Dr Khalida Parveen Adnan as Chief of lab, Karnataka

Similar News

Keeping Medicines Without Licence Amounts to 'Offer for Sale', HC Upholds Chemist's Conviction

Lupin Manufacturing Solutions: Empagliflozin API gets CADIFA approval from ANVISA, Brazil

Zydus Foundation Vice Chairperson Meha Patel appointed as Member of CII National Committee on Art & Culture for 2025-26

Eris Lifesciences Secures CDSCO Panel Nod to Conduct BE Study on Dapagliflozin, Pioglitazone, Metformin FDC

Delhi to form special committee to crush fake medicine racket

Roche Pharma teams up with 10 Govt Hospitals to power up clinical trial capacities in India

AstraZeneca's Proposal to Increase Sample Size in Zibotentan-Dapagliflozin Global Trial Gets SEC Nod

Govt Allows Stickering, Orders New MRPs Post GST Reduction, AiMeD Welcomes Directive